Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/μl

AIDS

Volumn 16, Issue 11, 2002, Pages 1551-1554

  Mussini, Cristina ^a   Bugarini, Roberto ^b   Perno, Carlo Federico ^c   Antinori, Andrea ^c   Borghi, Vanni ^a   Bertoli, Ada ^c   D'Arrigo, Roberta ^c   Bedini, Andrea ^a   Mongiardo, Nicola ^a   Cossarizza, Andrea ^d   Esposito, Roberto ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CELL KINETICS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT FAILURE; VIRUS LOAD; ADULT; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GENETICS; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LETTER; MALE; MUTATION; PATHOLOGY; PHYSIOLOGY; TIME; VIROLOGY;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENOTYPE; HIV; HIV INFECTIONS; HUMAN; LAMIVUDINE; MALE; MUTATION; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; VIRAL LOAD; HUMANS;

EID: 0037178332     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200207260-00013     Document Type: Article

References (7)

1. Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy
2. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
3. Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy
4. Impact of new antiretroviral combination therapies in HIV-infected patients in Switzerland: A prospective multicentre study
5. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy
6. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy
7. Analysis of mutation at position 184 in reverse transcriptase of human immunodeficiency virus type 1